LINDEN CAPITAL PARTNERS
LINDEN CAPITAL PARTNERS is a Series B, Series C+ and buyout fund in the US and Europe writing $10M–$50M checks into Healthcare and life-sciences.
- Stages
- Series B, Series C+, buyout
- Sectors
- Healthcare, life-sciences
- Check size
- $10M–$50M
- Invests in
- US-wide, Europe
- Actively investing
- Yes
- Founded
- 2004
- Assets under management
- $13.95B
- Website
- linden.com
Thesis
Linden Capital Partners is a private equity firm founded in 2004 and headquartered in Chicago, Illinois, with a strong focus on the healthcare and life sciences industries. The firm targets middle-market companies across various healthcare segments, including medical products, specialty distribution, pharmaceuticals, and healthcare services. Their investment strategy centers on control buyouts of privately held businesses, corporate carve-outs, and public companies, complemented by structured capital investments. Linden primarily operates within the United States, with some European presence noted. They invest at the Series B and Late Stage (Series C+) levels, focusing on growth and buyout stages, with typical check sizes ranging from $10 million to $50 million. As of December 31, 2025, the firm managed approximately $13.95 billion in AUM. Linden Capital Partners VI, closed in April 2025, raised $5.4 billion.
Common questions
Does LINDEN CAPITAL PARTNERS invest at the Series B stage?
Yes. LINDEN CAPITAL PARTNERS lists Series B, Series C+ and buyout among the stages it invests in.
What check size does LINDEN CAPITAL PARTNERS write?
LINDEN CAPITAL PARTNERS writes $10M–$50M checks.
Where does LINDEN CAPITAL PARTNERS invest?
LINDEN CAPITAL PARTNERS invests in the US and Europe.